| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036846 |
| Receipt No. | R000041976 |
| Scientific Title | Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan |
| Date of disclosure of the study information | 2019/05/27 |
| Last modified on | 2019/05/24 (Ver. 1) |
| Basic information | ||
| Public title | Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan | |
| Acronym | Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan | |
| Scientific Title | Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan | |
| Scientific Title:Acronym | Study of radiation therapy for lung cancer combined with interstitial lung disease in Japan | |
| Region |
|
|
| Condition | ||
| Condition | Lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the ratio of patients with interstitial lung disease who have received RT for lung cancer, the incidence of acute exacerbation in such patients, and the risk factors for acute exacerbation.
|
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The ratio of acute exacerbation
|
| Key secondary outcomes | The ratio of acute exacerbation related death
The ratio of interstitial lung disease on radiation therapy for lung cancer |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diagnosed as malignant tumor of lung.
Diagnosed as interstitial lung disease. Case of radiotherapy. |
|||
| Key exclusion criteria | Patients who have refused to use data. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Radiation Oncology Department | ||||||
| Zip code | 734-8551 | ||||||
| Address | Kasumi 4-9-1, Minami-ku Hiroshima, Japan | ||||||
| TEL | 082-257-1545 | ||||||
| nagat@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Yamagata University Faculty of Medicine | ||||||
| Division name | Department of Radiation Oncology | ||||||
| Zip code | 990-9585 | ||||||
| Address | Iidanishi 2-2-2, Yamagata, Japan | ||||||
| TEL | 023-628-5386 | ||||||
| Homepage URL | |||||||
| hagiwara.yasuhito@gmail.com | |||||||
| Sponsor | |
| Institute | Lung and Mediastinal Tumor Committee of Japanese Radiation Oncology Study Group (JROSG)
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kanagawa Cancer Center IRB |
| Address | Nakao 2-3-2, Asahi-ku, Yokohama, Japan |
| Tel | 045-520-2222 |
| chiken-jimu4@kcch.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 67 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041976 |